Women’s hormonal health telehealth has expanded significantly, with platforms now offering lab-based hormone evaluation, personalized hormone replacement therapy prescribing, and ongoing monitoring for perimenopause and menopause. The quality and clinical rigor of these services varies substantially, some are built around evidenced-based menopause medicine, others are built around selling supplements and low-intensity prescribing.
What Evidence-Based Women’s Hormone Telehealth Should Include
Initial hormone evaluation: A complete lab panel is the foundation. Minimum: estradiol, FSH, LH, testosterone (total and free or SHBG), progesterone (day 21 of cycle if premenopausal), TSH, and ferritin. Vitamin D, DHEA-S, and a complete blood count provide additional context. Platforms that do not include a lab panel as part of initial evaluation are not practicing to the standard of care for hormone prescribing.
Symptom assessment: Validated symptom questionnaires (Menopause Rating Scale, MSAQ, or equivalent) provide structured baseline assessment that allows tracking improvement over time.
Synchronous consultation: For hormone therapy, which involves ongoing prescribing of estrogen and/or progesterone, an initial real-time consultation with a licensed clinician (ideally an OB-GYN, internist, or NAMS-certified menopause specialist) is the appropriate standard. The North American Menopause Society (NAMS) certifies Menopause Practitioners, clinicians with specific menopause training and examination.
Individualized treatment selection: The choice between oral and transdermal estrogen, the type of progestin or whether to use bioidentical micronized progesterone, and the appropriate starting dose all depend on individual risk factors (cardiovascular history, clotting history, uterine status) that require clinical assessment.
Ongoing monitoring: Annual physical examination and breast health assessment, periodic lab rechecks, and symptom reassessment are part of appropriate ongoing HRT management.
What Platforms to Be Cautious About
Supplement-first platforms: Some women’s health platforms lead with botanical supplements and non-hormonal interventions before offering prescription access. While lifestyle and non-hormonal approaches have a role, platforms that push supplements with weak evidence ahead of evidence-based HRT may not prioritize patient benefit.
No lab requirement: A platform that prescribes hormones, particularly testosterone for women, without lab confirmation of hormone levels is not meeting appropriate clinical standards.
No licensed physician oversight: Platforms staffed entirely by naturopathic doctors or by nurse practitioners without physician oversight may not have the clinical training to manage hormone interactions, contraindications, or complications.
“Bioidentical” marketing: The term “bioidentical” is not an FDA-defined regulatory category. It is a marketing term. Compounded bioidentical hormones are not FDA-approved and do not have the same safety and efficacy data as FDA-approved hormone preparations. FDA-approved transdermal estradiol and micronized progesterone (Prometrium) are bioidentical in their molecular structure and have the evidence base to support them. Compounded “bioidentical” custom pellets do not.
Reputable Platforms to Know
Several platforms with menopause specialist access have emerged with evidence-based practice models. Midi Health, Alloy Women’s Health, and Gennev are platforms that have received positive characterization from menopause medicine specialists and that include physician oversight and lab evaluation. This is not an exhaustive list and inclusion is not an endorsement, verifying current practices before signing up is always appropriate.
The NAMS Menopause Practitioner Registry
The NAMS Menopause Practitioner registry lists clinicians who have passed the menopause specialty examination. Using this registry to find a menopause specialist, whether in-person or through telehealth, identifies providers with specific training in this area. Many menopause specialists now offer telehealth consultations.
For understanding the hormonal changes of perimenopause that these services address, see Perimenopause Symptoms: What Changes, When, and Why. For the evidence on HRT itself, see Hormone Replacement Therapy for Women: What the Current Evidence Shows.
